“Efficacy and Safety of Tyrosine Kinase 2 Inhibitor Deucravacitinib in Psoriasis : A Systematic Review and Drug-Response Meta Analysis of RCTs”. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, Dec. 2025, p. 10, https://doi.org/10.53366/jimki.vi.961.